InvestorsHub Logo

Lemoncat

10/23/20 12:49 PM

#329422 RE: Blue Fin #329412

providing an established safety and efficacy database on over 460 subjects



Well a safety database only with regard to COVID. Brilacidin has not been tested in humans against COVID or any other viral indication.

you should quit dropping the hints that Brilacidin is failing.



Agreed. We need to be able to start a clinical trial before we can succeed or fail.

Go IPIX!

steelyeye

10/23/20 8:12 PM

#329464 RE: Blue Fin #329412

Key points that many forget about, ignore, or simply don't know about:

Brilacidin is one of the few drugs targeting COVID-19 that has been tested in human trials (a total of 8) for other clinical indications, providing an established safety and efficacy database on over 460 subjects, thereby potentially enabling it to rapidly help address the novel coronavirus crisis.



COMBINE WITH THIS:

June 17, 2020
Innovation Pharmaceuticals’ Brilacidin Inhibits SARS-CoV-2 (COVID-19) by 97 Percent in a Human Lung Cell Line
Brilacidin
Data from Ongoing Testing at U.S. Regional Biocontainment Laboratory